Skip to Main Content

Paper Details

CpG island methylator phenotype in adenocarcinomas from the digestive tract: Methods, conclusions, and controversies.
World J Gastrointest Oncol
9
2017
BRAF V600E, CDKN2A, CIMP, Cancer, CpG, CpG island, CpG island methylator phenotype, CpG islands, DNA, MLH1, RNF43, WIF1, Wnt, adenocarcinomas, adenocarcinomas from the digestive tract, cancer, patients, tumor, tumor suppressor genes, tumors
Author NameAffiliation
Francisco VegaNational Human Genome Research Institute, National Institutes of Health
Valer GoteaNational Human Genome Research Institute, National Institutes of Health
Valer GoteaNational Human Genome Research Institute, National Institutes of Health
Laura ElnitskiNational Human Genome Research Institute, National Institutes of Health
Laura ElnitskiNational Human Genome Research Institute, National Institutes of Health
  • 1 - 5

Datasets

Release 1.2